-
The Socioeconomic Value of Adult Respiratory Immunization Programs in France: Can Improved Coverage Unlock Missed Gains?
Sep 9, 2025, 16:22 PM -
Patient Preferences for Type 2 Diabetes Mellitus (T2DM) Treatment: A Systematic Review of Discrete Choice Experiments Studies
Sep 9, 2025, 16:22 PM -
Dutch Cost Implications of Faricimab in Neovascular Age-Related Macular Degeneration: A Systematic Review of Treatment Interval and Injection Frequency
Sep 9, 2025, 16:22 PM -
Network Meta-Analysis of Survival Outcomes in the First-Line Treatment of Unresectable or Metastatic Melanoma: Scoping Review of Methodology
Sep 9, 2025, 16:22 PM -
Physicians' and Pharmacists’ Views on Implementing Generic Medicines Standard and Biosimilar Guide
Sep 9, 2025, 16:22 PM -
Treatment Characteristics of Breast Cancer Patients per HER2/HR Status in the United States: A Surveillance, Epidemiology, and End Results (SEER) 2018-2022 Database Analysis
Sep 9, 2025, 16:22 PM -
Evolution of Negotiations and Contracts for Reimbursement of Pharmaceuticals in Greece Between 2020 and 2025: Onwards and Upwards
Sep 9, 2025, 16:22 PM -
The Socioeconomic Burden of Dengue in Spain
Sep 9, 2025, 16:22 PM -
Optimizing a New Patient-Reported Outcome Instrument for Proliferative Diabetic Retinopathy: A Psychometric Study
Sep 9, 2025, 16:22 PM -
Economic Impact of Incorporating a Fecal Bacterial Signature to Optimize FIT-Based Colorectal Cancer Screening in Spain
Sep 9, 2025, 16:22 PM -
The Innovative Licensing and Access Pathway (ILAP): Early Pathway Experience, Examining, Process Adaptations, and Industry Impact
Sep 9, 2025, 16:22 PM -
Efficacy and Safety of Antibody-Drug Conjugates (ADCs) in Pretreated Breast Cancer: A Systematic Literature Review (SLR)
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness Analysis of Dostarlimab Plus Carboplatin-Paclitaxel in Primary Advanced or Recurrent Endometrial Cancer With Deficient Mismatch Repair (dMMR) and High Microsatellite Instability (MSI-H) in France
Sep 9, 2025, 16:22 PM -
Collecting Patient Preference Information (PPI) in In-Trial/Exit Interviews: Current Perspectives and Future Considerations
Sep 9, 2025, 16:22 PM -
Fragmentation in Access Pathways: A Review of HTA and Decision-Making Processes for Medicines in Finland
Sep 9, 2025, 16:22 PM -
Examination of Muscle Activity Among Aesthetic Sports Athletes
Sep 9, 2025, 16:22 PM -
Patient Perspectives on the Lifelong Impact of Preterm Birth in Chronic Respiratory Disease Care
Sep 9, 2025, 16:22 PM -
Methods for Incidence Progression Estimation in Partitioned Survival Analysis: Does the Chosen Method Matter?
Sep 9, 2025, 16:22 PM -
Implementing SISAQOL Recommendations: Insights From Cancer Clinical Trials
Sep 9, 2025, 16:22 PM -
The Uptake of R in NICE HTA: Insights From Technology Assessment Groups
Sep 9, 2025, 16:22 PM
